申请人:Gilead Sciences, Inc.
公开号:EP3012258A1
公开(公告)日:2016-04-27
The invention provides compounds of Formula I or Formula II:
or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
本发明提供了式 I 或式 II 的化合物:
或其药学上可接受的盐或酯。这些化合物及其组合物可用于治疗肺炎病毒感染。所提供的化合物、组合物和方法尤其适用于治疗人类呼吸道合胞病毒感染。